Abstract
Background: Bronchial asthma (BA) is a common chronic respiratory condition in children, characterized by recurring episodes of airway inflammation, wheezing, and breathing difficulties. Immune dysfunction and malnutrition often complicate the disease, worsening its severity and increasing the risk of recurrence. Despite ongoing treatment advancements, there is no definitive cure for BA, and management primarily revolves around symptom control and improving overall health. This study explores the combined therapeutic effects of pediatric massage and vitamin D supplementation on the nutritional status, immune function (serum IL-4 and IL-5 ) , and clinical outcomes in children with BA.
Methods: A total of 60 children diagnosed with BA were randomly assigned to one of two groups: a control group receiving conventional treatment alone, and an experimental group receiving conventional treatment alongside pediatric massage and daily vitamin D supplementation. Both groups were monitored over a two-month period for changes in clinical symptoms, immune markers (CD3+, CD4+, CD4+/CD8+ ratio), nutritional protein levels (albumin, transferrin, prealbumin, and total protein), and recurrence rates.
Results: The experimental group showed significantly faster symptom relief and improved immune function compared to the control group. This included enhanced immune markers, such as increased CD3+ and CD4+ counts and an improved CD4+/CD8+ ratio. Nutritional status also improved, as evidenced by higher levels of albumin, transferrin, prealbumin, and total protein. Additionally, the recurrence rate in the experimental group was notably lower (10%) compared to the control group. The experimental group also exhibited reduced levels of inflammatory cytokines, including IL-4 and IL-5, suggesting a beneficial effect on immune modulation.
Conclusion: The combination of pediatric massage and vitamin D supplementation significantly improves clinical outcomes in children with BA, enhancing immune function, nutritional status, and reducing the recurrence rate. This adjunctive therapy shows promise in managing BA in pediatric patients and warrants further investigation for its long-term effectiveness.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.